Advances in the Treatment of Metastatic Melanoma: Adoptive T-Cell Therapy

被引：36

作者：

Bernatchez, Chantale ^{[1
]}

Radvanyi, Laszlo G. ^{[1
]}

Hwu, Patrick ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77054 USA

来源：

SEMINARS IN ONCOLOGY | 2012年 / 39卷 / 02期

关键词：

TUMOR-INFILTRATING LYMPHOCYTES; IN-VIVO; PHASE-I; CANCER REGRESSION; AUTOLOGOUS TUMOR; MALIGNANT-MELANOMA; ANTITUMOR-ACTIVITY; ADVERSE EVENT; ANTIGEN; RECEPTOR;

D O I：

10.1053/j.seminoncol.2012.01.006

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

页码：215 / 226

页数：12

共 86 条

[1]

CD8+T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells [J].

Antony, PA ;

Piccirillo, CA ;

Akpinarli, A ;

Finkelstein, SE ;

Speiss, PJ ;

Surman, DR ;

Palmer, DC ;

Chan, CC ;

Klebanoff, CA ;

Overwijk, WW ;

Rosenberg, SA ;

Restifo, NP .

JOURNAL OF IMMUNOLOGY, 2005, 174 (05) :2591-2601

[2]

High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: Analysis of 270 patients treated between 1985 and 1993 [J].

Atkins, MB ;

Lotze, MT ;

Dutcher, JP ;

Fisher, RI ;

Weiss, G ;

Margolin, K ;

Abrams, J ;

Sznol, M ;

Parkinson, D ;

Hawkins, M ;

Paradise, C ;

Kunkel, L ;

Rosenberg, SA .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (07) :2105-2116

[3]

Benlalam H, 2001, EUR J IMMUNOL, V31, P2007, DOI 10.1002/1521-4141(200107)31:7<2007::AID-IMMU2007>3.0.CO

[4]

2-S

[5]

Infusion of Melan-A/Mart-1 specific tumor-infiltrating lymphocytes enhanced relapse-free survival of melanoma patients [J].

Benlalam, Houssem ;

Vignard, Virginie ;

Khammari, Amir ;

Bonnin, Annabelle ;

Godet, Yann ;

Pandolfino, Marie-Christine ;

Jotereau, Francine ;

Dreno, Brigitte ;

Labarriere, Nathalie .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2007, 56 (04) :515-526

[6]

Clinical Responses in a Phase II Study Using Adoptive Transfer of Short-term Cultured Tumor Infiltration Lymphocytes in Metastatic Melanoma Patients [J].

Besser, Michal J. ;

Shapira-Frommer, Ronnie ;

Treves, Avraham J. ;

Zippel, Dov ;

Itzhaki, Orit ;

Hershkovitz, Liat ;

Levy, Daphna ;

Kubi, Adva ;

Hovav, Einat ;

Chermoshniuk, Natalia ;

Shalmon, Bruria ;

Hardan, Izhar ;

Catane, Raphael ;

Markel, Gal ;

Apter, Sara ;

Ben-Nun, Alon ;

Kuchuk, Iryna ;

Shimoni, Avichai ;

Nagler, Arnon ;

Schachter, Jacob .

CLINICAL CANCER RESEARCH, 2010, 16 (09) :2646-2655

[7]

BODURTHA AJ, 1976, CANCER-AM CANCER SOC, V37, P735, DOI 10.1002/1097-0142(197602)37:2<735::AID-CNCR2820370221>3.0.CO

[8]

2-Z

[9]

Selective BRAFV600E Inhibition Enhances T-Cell Recognition of Melanoma without Affecting Lymphocyte Function [J].

Boni, Andrea ;

Cogdill, Alexandria P. ;

Dang, Ping ;

Udayakumar, Durga ;

Njauw, Ching-Ni Jenny ;

Sloss, Callum M. ;

Ferrone, Cristina R. ;

Flaherty, Keith T. ;

Lawrence, Donald P. ;

Fisher, David E. ;

Tsao, Hensin ;

Wargo, Jennifer A. .

CANCER RESEARCH, 2010, 70 (13) :5213-5219

[10]

Treatment of Chronic Lymphocytic Leukemia With Genetically Targeted Autologous T Cells: Case Report of an Unforeseen Adverse Event in a Phase I Clinical Trial [J].

Brentjens, Renier ;

Yeh, Raymond ;

Bernal, Yvette ;

Riviere, Isabelle ;

Sadelain, Michel .

MOLECULAR THERAPY, 2010, 18 (04) :666-668

← 1 2 3 4 5 6 7 8 9 →